Bluejay Diagnostics (BJDX) Common Equity (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Common Equity of $4.2 million for Q1 2026, down 30.03% sequentially from $6.0 million in Q4 2025, and up 8.14% YoY from $3.9 million in Q1 2025.
Bluejay Diagnostics (BJDX) Common Equity (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Common Equity for 7 years, with the latest figure at $4.2 million in Q1 2026.
- Quarterly Common Equity rose 8.14% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (up 8.14% YoY) and the FY2025 annual result came in at $6.0 million, up 4.29% from the prior year.
- Common Equity eased to $4.2 million in Q1 2026 per BJDX's latest filing, from $6.0 million in the prior quarter.
- Over five years, Common Equity peaked at $18.5 million in Q1 2022 and troughed at $2.9 million in Q4 2023.
- A 5-year average of $7.8 million and a median of $6.0 million in 2025 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2023: Common Equity jumped 13389.68% in 2022, then slumped 74.92% in 2023.
- Over 5 years, Common Equity stood at $11.5 million in 2022, then plunged by 74.92% to $2.9 million in 2023, then jumped by 97.92% to $5.7 million in 2024, then climbed by 4.29% to $6.0 million in 2025, then slumped by 30.03% to $4.2 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $4.2 million, $6.0 million, and $3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.41 Mn |
| Mar 31, 2026 | 4.18 Mn |
| Dec 31, 2025 | 5.98 Mn |
| Sep 30, 2025 | 3.69 Mn |
| Jun 30, 2025 | 5.29 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 5.73 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Dec 31, 2023 | 2.89 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Mar 31, 2023 | 9.16 Mn |
| Dec 31, 2022 | 11.54 Mn |
| Sep 30, 2022 | 13.81 Mn |
| Jun 30, 2022 | 16.66 Mn |
| Mar 31, 2022 | 18.49 Mn |
| Dec 31, 2021 | 20.38 Mn |
| Sep 30, 2021 | -1.08 Mn |